8-K: Intelligent Bio Solutions Updates Share Count

Intelligent Bio Solutions Inc. reported an updated total of 3,316,803 outstanding common shares as of September 10, 2026, following warrant exercises and restricted stock issuance.

Summary

• The total number of outstanding common shares for Intelligent Bio Solutions Inc. as of September 10, 2026, is 3,316,803.
• This update is a result of two events: the exercise of 285,000 prefunded warrants and the issuance of 4,333 restricted common shares.
• The restricted shares were issued under a previously disclosed Investor Relations and Corporate Development Advisory Agreement dated February 29, 2024.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral update, primarily providing factual information on share count changes without significant financial or strategic implications.

Positives

• The exercise of prefunded warrants indicates potential investor confidence or a mechanism to raise capital.
• Issuance of restricted stock under an advisory agreement suggests ongoing efforts in investor relations and corporate development.

Negatives

• The increase in outstanding shares dilutes existing shareholders' ownership percentage.

Risks

• Potential for further dilution if more warrants are exercised or restricted stock is issued.
• The impact of these share issuances on the stock's market price and trading liquidity is not detailed.

Future Outlook

No specific future outlook or guidance is provided in this filing; it is a factual update on share count.

Management Comments

• The filing is a factual disclosure of share count changes.
• Spiro Sakiris, Chief Financial Officer, signed the report, indicating CFO oversight of the disclosure.

Industry Context

StockSavvy.ai notes that updates to share counts are common for companies utilizing various financing and compensation instruments like warrants and restricted stock. The specific numbers here reflect routine corporate actions rather than a significant strategic shift.

Related Party Transactions

• The issuance of 4,333 shares of restricted common stock was pursuant to the previously disclosed Investor Relations and Corporate Development Advisory Agreement, dated February 29, 2024.

Stakeholder Impact

• Shareholders: Potential for slight dilution of ownership percentage due to increased share count.
• Investors: The update provides clarity on the company's capital structure and share count.

Next Steps

• Continue to monitor future filings for further updates on share count and potential dilutive events.
• Analyze the impact of share count changes on earnings per share (EPS) in future financial reports.

Key Dates

Keywords

shares outstanding, common stock, warrants, restricted stock, shareholder dilution, corporate development, investor relations